Found 232 clinical trials
Management of Acute Stroke Patients on Treatment with New Oral Anticoagulants: Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry”
Management of Acute Stroke Patients on Treatment with New Oral Anticoagulants: Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry”
- 284 views
- 25 Mar, 2021
- 1 location
Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry
Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry
- 68 views
- 08 Nov, 2020
- 1 location
BRIDGE: Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery
BRIDGE: Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery
- 30 views
- 25 Mar, 2021
- 1 location
Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes
NOAH is an investigator-initiated, prospective, parallel-group, double-blind, randomised, multi-centre trial. The objective of the trial is to demonstrate that oral anticoagulation using the NOAC edoxaban is superior to current therapy to pre-vent stroke, systemic embolism, or cardiovascular death in patients with AHRE and at least two stroke risk factors but …
- 0 views
- 23 Jan, 2021
- 16 locations
Use of Prothrombin Complex Concentrate in Patients Admitted in Emergency Care Units for Severe Bleeding While Receiving Oral Anticoagulants
The study is assessing the impact of an expert eCRF on the management of severe bleeding in the administration of Prothrombin Complex Concentrate in patients treated with oral anticoagulants and
- 6 views
- 25 Jan, 2021
- 44 locations
The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)
The purpose of this study is to investigate the efficacy and safety of non-vitamin K antagonist oral anticoagulants (NOAC) in atrial fibrillation patients with intermediate stroke risk (CHA2DS2
- 0 views
- 25 Jan, 2021
AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)
, anticoagulation can increase the risk of bleeding, the study evaluating the role of oral anticoagulation is needed in this patients. This study will compare the efficacy and safety of non-vitamin K anticoagulants
- 0 views
- 24 Jan, 2021
STOPping Anticoagulation for Isolated or Incidental Subsegmental Pulmonary Embolism
(SSPE). Anticoagulants are used to treat SSPE and work by preventing new clots from forming whilst the body's own mechanisms break down the clots, however they can also increase the risk of major and
- 0 views
- 25 Apr, 2021
- 1 location
Clinical Study of Argatroban in the Treatment of Acute Progressive Ischemic Stroke
thrombin inhibitor. Its mechanism of action is to bind and inactivate thrombin (factor a) directly.Compared with traditional anticoagulants, argatroban not only has the advantages of good anticoagulant
- 0 views
- 25 Jan, 2021
- 6 locations